May 2021
Cancer in Focus
The latest insights and updates on cancer screening and diagnostics
Business
Changes to FDA Oversight of Lab-Developed Tests
Changes to FDA Oversight of Lab-Developed Tests
The decision to revoke FDA oversight of LDTs is no longer clear after HHS removed its initial statement
Monitoring How Tumors Respond to Treatment with ctDNA
Monitoring How Tumors Respond to Treatment with ctDNA
ctDNA assays can facilitate tracking of a tumor's response to treatment over time
Management
Strategies to Improve Lab Staff Retention
Strategies to Improve Lab Staff Retention
How to build stronger working relationships that will ultimately reduce staff turnover
Danger in the Clinical Lab
Danger in the Clinical Lab
What to do when an emergency strikes in your clinical lab
Technology
Insight
How the Pandemic Has Impacted Cancer Screening
How the Pandemic Has Impacted Cancer Screening
Delayed cancer screening due to COVID-19 could mean more cancer-related deaths for years to come
Do Cancer Genetic Testing Criteria Need an Overhaul?
Do Cancer Genetic Testing Criteria Need an Overhaul?
Universal genetic testing could offer a middle ground between guideline-based and population-based testing
Thought Leadership
The Technologies that Helped COVID-19 Testing Labs Scale Up
The Technologies that Helped COVID-19 Testing Labs Scale Up
Lab automation can help labs overcome challenges exacerbated by the pandemic to increase testing
The Evolution of Clinical Flow Cytometry
The Evolution of Clinical Flow Cytometry
A look at the technological advances that have simplified the use of flow cytometry in clinical labs
Novel Complex Cell Manufacturing
Novel Complex Cell Manufacturing
Challenges and critical considerations for the manufacturing of cellular therapies
